CSL pays $275m to acquire Novartis’ flu vaccines, three manufacturing sites
CSL Limited has agreed to acquire Novartis’ flu vaccine business for $275m (€216m), which includes manufacturing facilities in the US, UK and Germany.
Archives for October 28, 2014
Fujifilm to buy BARDA contractor Kalon Therapeutics
Texas, US-based GSK influenza vaccine partner Kalon Therapeutics has agreed to a takeover by Japanese conglomerate Fujifilm.
Swissmedic OKs trial of GSK's adenovirus-based Ebola vaccine
Swiss approval for a trial of an a Ebola vaccine candidate developed by GSK has been welcomed by the World Health Organisation (WHO).